01760oam 2200493 450 991070835680332120180323151259.0(CKB)3460000000106669(OCoLC)852784169(OCoLC)654992341(OCoLC)760056613(OCoLC)1012086687(OCoLC)1022024867(EXLCZ)99346000000010666920130713d2001 ua 0engurbn||||a||||txtrdacontentcrdamediacrrdacarrierContinuing concerns over imported pharmaceuticals hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 7, 2001Washington :U.S. Government Printing Office,2001.1 online resource (iii, 191 pages) illustrations"Serial No. 107-30."Includes bibliographical references.Continuing concerns over imported pharmaceuticals DrugsInspectionUnited StatesDrug adulterationGovernment policyUnited StatesPharmaceutical industryUnited StatesQuality controlDrugsInspectionDrug adulterationGovernment policyPharmaceutical industryQuality control.OCLCEOCLCEOCLCOOCLCAOCLCQOCLCOOCLCFOCLCAOCLCQNJROCLCQGPOBOOK9910708356803321Continuing concerns over imported pharmaceuticals3468668UNINA